Exploration of extracellular vesicles from porcine endometrial cells for enhancing the development of parthenogenetic embryos Authors: Shao-Yu Peng, Yen Feng, Min-Jung Lin, Shen-Chang Chang, Jung-Wen Huang, Perng-Chih Shen, Kuo-Tai Yang, Chao-Wei Huang, Chih-Jen Chou, Steven W. Shaw Published: 2026 ABSTRACT Highlights•Porcine endometrial mesenchymal stem cells (PEMSCs) secrete extracellular vesicles (EVs) containing bioactive microRNAs (miRNAs).•PEMSC-conditioned medium promotes porcine oocyte maturation during in vitro maturation (IVM).•miR-21-5p supplementation during IVM significantly increases blastocyst formation rate in parthenogenetic porcine embryos.•miR-21-5p acts via downregulation of CDK2AP1, thereby promoting Oct4 (POU5F1) expression in blastocysts.•miR-143-3p increases the eight-cell cleavage rate, suggesting a role in early embryonic cell division. Introduction In recent years, assisted reproductive technologies (ARTs) have been widely utilized, such as in vitro production (IVP) and vitrification, to produce and preserve embryos. These artificial technologies have been used to treat human reproductive disorders and breed commercial livestock. However, the maturity rate of in vitro maturation (IVM) and the development rate of in vitro culture (IVC) through the IVP of porcine oocytes, such as in parthenogenetic activation and in vitro fertilization (IVF), still exhibit lower efficiency compared to those achieved under in vivo conditions. The pig is used as a model in this study because of its physiological similarity to humans and its direct relevance to livestock production. Many studies have demonstrated that co-culturing oocytes, cumulus cells, and embryos can alleviate the embryo blocking period during in vitro embryo culture, promote embryo growth to the morula and blastocyst stages, increase the expression of genes related to oocyte maturation and embryo development, reduce reactive oxygen species levels, and improve the development rate and viability after embryo cryopreservation and thawing (Godke et al., 2014; Lee et al., 2018; Lopera-Vasquez et al., 2017; Schmaltz-Panneau et al., 2015). These effects are largely dependent on various molecules secreted by these cells. Cells release extracellular vesicles (EVs) into the extracellular space through paracrine secretion, acting as carriers to transport various molecules. EVs can be classified as exosomes, microvesicles, and apoptotic bodies based on size, and they carry specific molecules, including proteins, lipids, and nucleic acids (mRNA, miRNA, DNA), among others. Receptor cells absorb EVs through mechanisms such as direct fusion, endocytosis, and pinocytosis, thereby affecting cellular and tissue mechanisms (Tannetta et al., 2014). In recent years, EVs have been extensively researched for their involvement in various reproductive processes, including follicle development, embryo development, and implantation. EVs may play an important role in cellular communication between the endometrium and blastocysts, which is related to increasing blastocyst adhesion (Cuman et al., 2015; Es-Haghi et al., 2019; Homer et al., 2017). In porcine reproduction specifically, EVs in uterine fluid have been shown to regulate conceptus elongation and maternal-embryonic communication. Utilizing EVs to improve the development and quality of in vitro embryos is significant for assisted reproductive technologies and regenerative medicine research. Nowadays, comprehensive research often uses pregnant sow uterine fluid, which contains EVs secreted by the endometrium, stromal cells, and embryos. The impact of miRNA in porcine endometrial mesenchymal stem cell (PEMSC)-derived EVs on porcine blastocysts needs further investigation. Although EVs produced by luminal and glandular epithelial cells represent the most physiologically direct source for uterine-embryo communication, PEMSCs provide an accessible and abundant in vitro source of MSC-derived EVs that can be characterized and applied in experimental settings. Therefore, the objectives of this study are as follows: Experiment 1 aims to establish a PEMSC culture system; Experiment 2 aims to isolate and identify EVs secreted by PEMSCs and analyze their miRNA content; Experiment 3 aims to select miRNAs that promote porcine embryo development and add them to the in vitro medium to observe maturation and development; Experiment 4 aims to examine changes in gene expression in IVC blastocysts after the addition of miRNAs. Materials and methods Animals Porcine ovaries and uteri were obtained from a local abattoir (Pingtung County, Linluo Township, Taiwan). Animals were of mixed reproductive status, and the specific stage of the estrous cycle was not recorded, as tissues were collected from routine commercial slaughter. This is acknowledged as a limitation of the study. Establishment of PEMSCs culture Preparation of Culture Medium: Minimum essential medium (MEM; Sigma, M-0894, USA) was dissolved in ultrapure water with 2.2 g NaHCO3, adjusted to pH 7.22, filtered through a 0.22 μm membrane, and supplemented with 1% penicillin-streptomycin (P/S) and 10% fetal bovine serum (FBS). Medium was stored at 4°C. Establishment of Primary PEMSCs: Porcine uterine tissue was transported to the laboratory within 30 minutes in 0.9% saline with 0.1 mg/mL P/S at 37–39°C. Under sterile conditions, approximately 0.5 cm² of endometrial tissue was excised and placed into MEM with 10% FBS. Tissue was cut into ∼0.1 cm² pieces and cultured in 10 cm dishes using an explant outgrowth method, without enzymatic digestion. Cells migrating from the explants and adhering to the dish surface were identified as PEMSCs based on their fibroblast-like morphology. Medium was replaced every three days. This explant method selectively favors outgrowth of stromal mesenchymal cells over epithelial cells. Cells were subcultured until the 5th generation. Characterization of PEMSCs: PEMSC identity was confirmed by: (1) fibroblast-like spindle-shaped morphology; (2) successful adipogenic differentiation confirmed by Oil Red O staining; (3) successful osteogenic differentiation confirmed by Alizarin Red S staining; and (4) immunophenotyping showing expression of MSC-positive markers (CD44, CD90) and absence of hematopoietic markers (CD34, CD45). Subculture, Cryopreservation, and Thawing: At 80% confluence, PEMSCs were passaged using 0.25% trypsin-EDTA, centrifuged at 270 × g for 5 min, and replated. For cryopreservation, cells at 90% confluence were resuspended in DMSO:FBS (1:9) and stored in liquid nitrogen. Thawed cells were plated directly and medium was changed within 24 h to remove cryoprotectant. Collection of PEMSC-conditioned medium (CM) Fifth-generation PEMSCs grown to 80–90% confluence were washed three times with DPBS. After washing three times with DPBS, the cells were incubated in 3 mL of IVM (TCM-199) or IVC (PZM) medium for 3 hours at 38.5°C with 5% CO2 to prepare the conditioned medium. The medium was then filtered through a 0.22 μm filter and stored at 4°C for use within one week. EV collection and analysis Fifth-generation PEMSCs at 80–90% confluence were washed three times with DPBS, and 3 mL of EV extraction medium was added and incubated for 3 hours. EVs were isolated using the miRCURY Exosome Kit (Qiagen, 76743, Germany) per manufacturer's instructions, then filtered (0.22 μm) and centrifuged at 3,200 × g for 30 minutes. The EV pellet was resuspended in 100 μL preservative buffer and stored at −20°C. Nanoparticle tracking analysis (NTA) was performed using a Malvern Panalytical NanoSight LM10HS instrument (UK) at the Micro and Nano Technology Research Center, National Cheng Kung University, to determine EV size distribution and concentration. Western blotting analysis Proteins (40 μg/lane) were separated by SDS-PAGE using TGX Stain-Free™ FastCast™ Acrylamide (Bio-Rad, 161-0185, USA) at 200 V for 40–60 min, then transferred to PVDF membrane at 0.2 A for 2.5 h. Membranes were blocked and incubated with primary antibodies: β-Actin (1:5,000; Thermo Fisher, MA5-11869), Cyt c (1:5,000; Proteintech, 10993-1-AP), and CD9 (1:1,000; Sigma, SAB4503606). HRP-conjugated secondary antibodies were applied, and bands were visualized using Immobilon Crescendo HRP substrate. Band density was quantified using Bio-imaging camera system analysis software and normalized to β-Actin as the endogenous loading control. miRNA analysis (NGS) Total miRNA was extracted from EVs using the Vazyme NR801 kit and submitted to Topgen Biotechnology Co., Ltd. for next-generation sequencing (NGS). The 12 most highly expressed miRNAs were used for Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. In vitro maturation (IVM) of porcine oocytes IVM medium was prepared by supplementing TCM-199 (GibcoTM, 12340-030, USA) with 10% FBS, 10 μL FSH, 20 μL hCG, 1% antibiotic-antimycotic (ABAM), and 10% porcine follicular fluid (PFF). Note: PFF was included in all groups equally; although PFF may contain endogenous EVs, its consistent use across all experimental and control groups means that any EV contribution from this source would not confound group comparisons. Cumulus-oocyte complexes (COCs) were aspirated from follicles, washed with modified PBS, and cultured in TCM-199 under mineral oil at 38.5°C, 5% CO2 for 44 hours. Maturity was confirmed by first polar body extrusion. Parthenogenetic activation and in vitro culture (IVC) Mature oocytes were activated with 5 μM A23187 for 5 min in darkness at 38.5°C, followed by 2 mM 6-DMAP for 4 h. Oocytes were washed three times with Porcine Zygote Medium (PZM) and cultured in PZM (PZM: Porcine Zygote Medium) under mineral oil for 7–8 days at 38.5°C, 5% CO2. Fresh PZM was replaced every two days. Embryonic stage, blastocyst rate, and cell count were recorded. Synthetic miRNA transfection Synthetic miRNAs (DSMIR02, TopGen, Taiwan) were prepared at 20 μM in ddH2O. Before use, 1 μL miRNA was mixed with 3 μL HiPerFect® Transfection Reagent (QIAGEN, 301707, Germany) for 5–10 min at room temperature, then diluted in TCM-199 to a final concentration of 200 nM. miRNAs (ssc-miR-21-5p, ssc-miR-143-3p, ssc-miR-381-3p) were added at 50 nM to IVM or IVC medium as per experimental design. See Table 1 for sequences.Table 1The sequences of miRNA and RT-qPCR primers.Table 1 dummy alt textmicroRNASequenceAmplicon Lengthssc-miR-21-5pUAGCUUAUCAGACUGAUGUUGAssc-miR-143-3pUGAGAUGAAGCACUGUAGCUCssc-miR-381-3pUAUACAAGGACAAGCUCUCUGUssc-miR-21-5p-mimicmU*mC*mAmAmCmAmUmCmAmGmUmCmUmGmAmUmAmA*mG*mC*mU*mA/CholGene PrimerSequence (5′-3′)GAPDH-FATTGCCCTCAACGACCACTT103 bpGAPDH-RCCTTGGAGGCCATGTGGACDK2AP1-FCTTCACAGTACCGCCAGCTG106 bpCDK2AP1-RAGCAGCTCAGCGTATTTGCTCPOU5F1-FCTCCTAAAGCAGAAGAGGATCACC133 bpPOU5F1-RTCTTGAAACTGAGCTGCAAAGCm: Chemical Modification, 2′-Ome. *, phosphorothioate. Chol, Cholesterol Table 1The sequences of miRNA and RT-qPCR primers.Table 1 dummy alt textmicroRNASequenceAmplicon Lengthssc-miR-21-5pUAGCUUAUCAGACUGAUGUUGAssc-miR-143-3pUGAGAUGAAGCACUGUAGCUCssc-miR-381-3pUAUACAAGGACAAGCUCUCUGUssc-miR-21-5p-mimicmU*mC*mAmAmCmAmUmCmAmGmUmCmUmGmAmUmAmA*mG*mC*mU*mA/CholGene PrimerSequence (5′-3′)GAPDH-FATTGCCCTCAACGACCACTT103 bpGAPDH-RCCTTGGAGGCCATGTGGACDK2AP1-FCTTCACAGTACCGCCAGCTG106 bpCDK2AP1-RAGCAGCTCAGCGTATTTGCTCPOU5F1-FCTCCTAAAGCAGAAGAGGATCACC133 bpPOU5F1-RTCTTGAAACTGAGCTGCAAAGCm: Chemical Modification, 2′-Ome. *, phosphorothioate. Chol, Cholesterol The sequences of miRNA and RT-qPCR primers. m: Chemical Modification, 2′-Ome. *, phosphorothioate. Chol, Cholesterol RT-qPCR analysis Oocytes and day-8 blastocysts were washed three times with DPBS and stored at −80°C in QIAzol® lysis reagent. RNA was extracted using RNA Isolater Total RNA Extraction Reagent (Vazyme, China), reverse-transcribed with HiScript III RT SuperMix (37°C, 15 min; 85°C, 5 sec), and amplified by SYBR Green qPCR (ChamQ Universal SYBR qPCR Master Mix, Vazyme) on a StepOnePlus Real-Time PCR system (Applied Biosystems). Data were normalized to GAPDH using the 2−ΔΔCT method. Coefficient of variation was maintained below 2%. Design of experiments Experiment 1The conditioned medium (CM) approach was used to evaluate PEMSC secretions on embryo development. During IVM, COCs cultured without CM were divided for IVC without CM (Control) or IVC with CM (Treatment 1, T1). In a parallel setup, COCs cultured with CM during IVM were divided for IVC without CM (Treatment 2, T2) or IVC with CM (Treatment 3, T3) (Fig. 1A). Maturation rate, blastocyst rate, and total cell number were recorded.Fig. 1Experimental design for CM and miRNA supplementation. (A) Experiment 1: COCs were cultured in standard TCM-199 or PEMSC-conditioned medium (CM) during IVM, then allocated to IVC with PZM (PZM: Porcine Zygote Medium) or CM. (B) Experiment 3: COCs were cultured with or without miRNA in TCM-199 during IVM, then allocated to IVC with PZM or miRNA-supplemented PZM. CM: conditioned medium prepared by co-incubating PEMSCs with TCM-199 or PZM for 3 hours.Fig 1 dummy alt text The conditioned medium (CM) approach was used to evaluate PEMSC secretions on embryo development. During IVM, COCs cultured without CM were divided for IVC without CM (Control) or IVC with CM (Treatment 1, T1). In a parallel setup, COCs cultured with CM during IVM were divided for IVC without CM (Treatment 2, T2) or IVC with CM (Treatment 3, T3) (Fig. 1A). Maturation rate, blastocyst rate, and total cell number were recorded.Fig. 1Experimental design for CM and miRNA supplementation. (A) Experiment 1: COCs were cultured in standard TCM-199 or PEMSC-conditioned medium (CM) during IVM, then allocated to IVC with PZM (PZM: Porcine Zygote Medium) or CM. (B) Experiment 3: COCs were cultured with or without miRNA in TCM-199 during IVM, then allocated to IVC with PZM or miRNA-supplemented PZM. CM: conditioned medium prepared by co-incubating PEMSCs with TCM-199 or PZM for 3 hours.Fig 1 dummy alt text Experimental design for CM and miRNA supplementation. (A) Experiment 1: COCs were cultured in standard TCM-199 or PEMSC-conditioned medium (CM) during IVM, then allocated to IVC with PZM (PZM: Porcine Zygote Medium) or CM. (B) Experiment 3: COCs were cultured with or without miRNA in TCM-199 during IVM, then allocated to IVC with PZM or miRNA-supplemented PZM. CM: conditioned medium prepared by co-incubating PEMSCs with TCM-199 or PZM for 3 hours. Experiment 2EVs were isolated from fifth-generation PEMSC-conditioned medium, characterized by NTA and Western blot, and analyzed by NGS for miRNA content. GO and KEGG pathway analyses were performed on the 12 most highly expressed miRNAs (Table 2).Table 2Effects of IVM /IVC with PEMSCs CM on the development of parthenogenetic activation porcine embryos.Table 2 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2 cells (%)4 cells (%)8 cells (%)Morula (%)Blastocysts (%)Control249159(67.15±3.55)b64(95.28±2.07)57(86.12±4.18)a35(53.92±7.20)19(28.10±4.05)3(12.91±5.07)35.33±8.01T162(90.10±7.75)52(72.49±8.42)ab38(52.94±6.83)22(37.24±1.64)5(12.07±2.46)30.67±3.28T2266220(79.22±2.90)a74(93.02±1.81)64(82.13±3.95)a43(56.88±6.51)28(38.82±7.53)9(14.26±5.52)31.83±5.12T362(89.91±1.34)44(62.66±5.09)b30(45.92±6.10)19(29.70±6.17)4(11.05±1.74)27.75±5.94CM: Co-culture of PEMSCs with TCM-199 or PZM. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ CM medium for IVC.T2: CM medium for IVM/ PZM medium for IVC. T3: CM medium for IVM/CM medium for IVC.a,brepresents the significant difference (p < 0.05), value were presented as Mean ± SEM. This experiment was repeated six times. EVs were isolated from fifth-generation PEMSC-conditioned medium, characterized by NTA and Western blot, and analyzed by NGS for miRNA content. GO and KEGG pathway analyses were performed on the 12 most highly expressed miRNAs (Table 2).Table 2Effects of IVM /IVC with PEMSCs CM on the development of parthenogenetic activation porcine embryos.Table 2 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2 cells (%)4 cells (%)8 cells (%)Morula (%)Blastocysts (%)Control249159(67.15±3.55)b64(95.28±2.07)57(86.12±4.18)a35(53.92±7.20)19(28.10±4.05)3(12.91±5.07)35.33±8.01T162(90.10±7.75)52(72.49±8.42)ab38(52.94±6.83)22(37.24±1.64)5(12.07±2.46)30.67±3.28T2266220(79.22±2.90)a74(93.02±1.81)64(82.13±3.95)a43(56.88±6.51)28(38.82±7.53)9(14.26±5.52)31.83±5.12T362(89.91±1.34)44(62.66±5.09)b30(45.92±6.10)19(29.70±6.17)4(11.05±1.74)27.75±5.94CM: Co-culture of PEMSCs with TCM-199 or PZM. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ CM medium for IVC.T2: CM medium for IVM/ PZM medium for IVC. T3: CM medium for IVM/CM medium for IVC.a,brepresents the significant difference (p < 0.05), value were presented as Mean ± SEM. This experiment was repeated six times. Table 2Effects of IVM /IVC with PEMSCs CM on the development of parthenogenetic activation porcine embryos.Table 2 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2 cells (%)4 cells (%)8 cells (%)Morula (%)Blastocysts (%)Control249159(67.15±3.55)b64(95.28±2.07)57(86.12±4.18)a35(53.92±7.20)19(28.10±4.05)3(12.91±5.07)35.33±8.01T162(90.10±7.75)52(72.49±8.42)ab38(52.94±6.83)22(37.24±1.64)5(12.07±2.46)30.67±3.28T2266220(79.22±2.90)a74(93.02±1.81)64(82.13±3.95)a43(56.88±6.51)28(38.82±7.53)9(14.26±5.52)31.83±5.12T362(89.91±1.34)44(62.66±5.09)b30(45.92±6.10)19(29.70±6.17)4(11.05±1.74)27.75±5.94CM: Co-culture of PEMSCs with TCM-199 or PZM. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ CM medium for IVC.T2: CM medium for IVM/ PZM medium for IVC. T3: CM medium for IVM/CM medium for IVC.a,brepresents the significant difference (p < 0.05), value were presented as Mean ± SEM. This experiment was repeated six times. Effects of IVM /IVC with PEMSCs CM on the development of parthenogenetic activation porcine embryos. CM: Co-culture of PEMSCs with TCM-199 or PZM. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ CM medium for IVC. T2: CM medium for IVM/ PZM medium for IVC. T3: CM medium for IVM/CM medium for IVC. represents the significant difference (p < 0.05), value were presented as Mean ± SEM. This experiment was repeated six times. Experiment 3Based on NGS results, ssc-miR-21-5p, ssc-miR-143-3p, and ssc-miR-381-3p were selected for evaluation. The same design as Experiment 1 was applied, with CM replaced by miRNA (Fig. 1B). Maturation rate, embryonic stage rates, and blastocyst rate were recorded (Table 3).Table 3The top 12 miRNAs with the highest expression levels based on the analysis of PEMSCs EVs.Table 3 dummy alt textmiRNAAliasLengthRawRPMssc-miR-143-3pMIMAT001387921307377472981.6ssc-miR-148a-3pMIMAT000212422143177220316.0ssc-miR-381-3pMIMAT003738022133601205580.8ssc-miR-21-5pMIMAT0002165221022915740.0ssc-miR-100MIMAT001391122850513087.2ssc-miR-151-3pMIMAT00138832253428220.1ssc-miR-423-5pMIMAT00138802344966918.3ssc-miR-27b-3pMIMAT00138902135725496.5ssc-miR-378MIMAT00138682234845361.1ssc-miR-22-3pMIMAT00157102234055239.5ssc-miR-24-3pMIMAT00021342232174950.2ssc-miR-6529MIMAT00416112122543468.4Selection criteria: RPM > 2,000; Raw: expression level (raw count), RPM: expression level (normalized) Based on NGS results, ssc-miR-21-5p, ssc-miR-143-3p, and ssc-miR-381-3p were selected for evaluation. The same design as Experiment 1 was applied, with CM replaced by miRNA (Fig. 1B). Maturation rate, embryonic stage rates, and blastocyst rate were recorded (Table 3).Table 3The top 12 miRNAs with the highest expression levels based on the analysis of PEMSCs EVs.Table 3 dummy alt textmiRNAAliasLengthRawRPMssc-miR-143-3pMIMAT001387921307377472981.6ssc-miR-148a-3pMIMAT000212422143177220316.0ssc-miR-381-3pMIMAT003738022133601205580.8ssc-miR-21-5pMIMAT0002165221022915740.0ssc-miR-100MIMAT001391122850513087.2ssc-miR-151-3pMIMAT00138832253428220.1ssc-miR-423-5pMIMAT00138802344966918.3ssc-miR-27b-3pMIMAT00138902135725496.5ssc-miR-378MIMAT00138682234845361.1ssc-miR-22-3pMIMAT00157102234055239.5ssc-miR-24-3pMIMAT00021342232174950.2ssc-miR-6529MIMAT00416112122543468.4Selection criteria: RPM > 2,000; Raw: expression level (raw count), RPM: expression level (normalized) Table 3The top 12 miRNAs with the highest expression levels based on the analysis of PEMSCs EVs.Table 3 dummy alt textmiRNAAliasLengthRawRPMssc-miR-143-3pMIMAT001387921307377472981.6ssc-miR-148a-3pMIMAT000212422143177220316.0ssc-miR-381-3pMIMAT003738022133601205580.8ssc-miR-21-5pMIMAT0002165221022915740.0ssc-miR-100MIMAT001391122850513087.2ssc-miR-151-3pMIMAT00138832253428220.1ssc-miR-423-5pMIMAT00138802344966918.3ssc-miR-27b-3pMIMAT00138902135725496.5ssc-miR-378MIMAT00138682234845361.1ssc-miR-22-3pMIMAT00157102234055239.5ssc-miR-24-3pMIMAT00021342232174950.2ssc-miR-6529MIMAT00416112122543468.4Selection criteria: RPM > 2,000; Raw: expression level (raw count), RPM: expression level (normalized) The top 12 miRNAs with the highest expression levels based on the analysis of PEMSCs EVs. Selection criteria: RPM > 2,000; Raw: expression level (raw count), RPM: expression level (normalized) Experiment 4Based on Experiment 3 results, the miR-21-5p T2 group (miRNA in IVM only) was selected. Synthetic miR-21-5p (21+), miR-21-5p inhibitor (21−), and a control were added. Blastocyst rate, total cell number, and RT-qPCR gene expression of CDK2AP1 and POU5F1 (Oct4) were evaluated. Based on Experiment 3 results, the miR-21-5p T2 group (miRNA in IVM only) was selected. Synthetic miR-21-5p (21+), miR-21-5p inhibitor (21−), and a control were added. Blastocyst rate, total cell number, and RT-qPCR gene expression of CDK2AP1 and POU5F1 (Oct4) were evaluated. Statistical analysis Data were analyzed using SAS version 9.4. Duncan's new multiple range test was used for group comparisons, with statistical significance defined as p < 0.05. Results Experiment 1: Effects of PEMSC-conditioned medium on oocyte maturation and embryo development As shown in Table 4, supplementation with PEMSC-conditioned medium during IVM significantly increased oocyte maturation rates compared to standard TCM-199 (p < 0.05). Supplementation with PEMSC-conditioned medium during the IVC stage significantly influenced the proportion of embryos reaching the 4-cell stage (p < 0.05). No significant differences were observed in 8-cell, morula, blastocyst rates, or total cell numbers among groups.Table 4The potential target genes might related/ linked to the selected 12 miRNAs.Table 4 dummy alt textTarget geneFunctionCandidated miRNAReferenceFGF1Regulates granulosa cell proliferation and differentiation, cell proliferation, differentiation, migration, steroidogenesis, and angiogenesis in meal and embryonic development.miR-21-5p,miR-143-3p,miR-381-3p,miR-27b-3pAsakai et al., 1994; Sugiura et al., 2007; Chaves et al., 2012; Jiang et al., 2013VEGFARegulates proliferation,migration, and survival of embryonic endothelial cells.miR-381-3p,miR-148a-3p,miR-24-3pWulff et al., 2001; McFee et al., 2012MAPK 1,MAPK7,MAPK10,MAPK14Transmit extracellular signals to the cytoplasm and nucleus to regulate mitosis, cell differentiation and cell cycle.miR-22-3p,miR-21-5p,miR-381-3p,miR-27b-3p,miR-143-3p,miR-24-3pSu et al., 2003; Fan and Sun, 2004; Chen et al., 2020 Table 4The potential target genes might related/ linked to the selected 12 miRNAs.Table 4 dummy alt textTarget geneFunctionCandidated miRNAReferenceFGF1Regulates granulosa cell proliferation and differentiation, cell proliferation, differentiation, migration, steroidogenesis, and angiogenesis in meal and embryonic development.miR-21-5p,miR-143-3p,miR-381-3p,miR-27b-3pAsakai et al., 1994; Sugiura et al., 2007; Chaves et al., 2012; Jiang et al., 2013VEGFARegulates proliferation,migration, and survival of embryonic endothelial cells.miR-381-3p,miR-148a-3p,miR-24-3pWulff et al., 2001; McFee et al., 2012MAPK 1,MAPK7,MAPK10,MAPK14Transmit extracellular signals to the cytoplasm and nucleus to regulate mitosis, cell differentiation and cell cycle.miR-22-3p,miR-21-5p,miR-381-3p,miR-27b-3p,miR-143-3p,miR-24-3pSu et al., 2003; Fan and Sun, 2004; Chen et al., 2020 The potential target genes might related/ linked to the selected 12 miRNAs. Experiment 2: Characterization of PEMSC-derived EVs and miRNA profile Western blot confirmed that isolated EVs were enriched for CD9 (EV marker) and devoid of Cyt c (apoptosis marker), indicating absence of cellular contamination (Fig. 2). β-Actin served as loading control. NTA revealed EVs with a size range of 80–160 nm and mean diameter of 113 nm, consistent with exosome classification (Fig. 3).Fig. 2Western blot analysis of CD9, Cytochrome c (Cyt c), and β-Actin in PEMSCs and isolated EVs. CD9 expression was significantly higher in EVs than in PEMSCs, confirming EV enrichment. Cyt c was present in PEMSCs but absent in EVs, confirming the absence of cellular debris. β-Actin served as an endogenous loading control. *p < 0.05. Each lane contains 40 μg protein.Fig 2 dummy alt textFig. 3Nanoparticle tracking analysis (NTA) of PEMSC-derived EVs. The mean EV diameter was 113 nm, with a size distribution of 80–160 nm, consistent with the exosome size range.Fig 3 dummy alt text Western blot analysis of CD9, Cytochrome c (Cyt c), and β-Actin in PEMSCs and isolated EVs. CD9 expression was significantly higher in EVs than in PEMSCs, confirming EV enrichment. Cyt c was present in PEMSCs but absent in EVs, confirming the absence of cellular debris. β-Actin served as an endogenous loading control. *p < 0.05. Each lane contains 40 μg protein. Nanoparticle tracking analysis (NTA) of PEMSC-derived EVs. The mean EV diameter was 113 nm, with a size distribution of 80–160 nm, consistent with the exosome size range. NGS identified 92 miRNA species in PEMSC-derived EVs. GO analysis of the top 12 miRNAs revealed associations with embryonic morphogenesis, cell proliferation, and cell differentiation (Fig. 4). KEGG analysis implicated the MAPK and PI3K-AKT signaling pathways (Fig. 5), both of which are relevant to meiosis and cell cycle regulation.Fig. 4Gene Ontology (GO) analysis of target genes of the 12 most highly expressed miRNAs in PEMSC-derived EVs. Significantly enriched biological process terms include embryonic morphogenesis, regulation of cell population proliferation, and embryo development (p < 0.04).Fig 4 dummy alt textFig. 5KEGG pathway analysis of target genes of the 12 most highly expressed miRNAs in PEMSC-derived EVs. The most significantly enriched pathways include the MAPK and PI3K-AKT signaling pathways (p < 0.03), which are involved in meiosis and cell cycle regulation.Fig 5 dummy alt text Gene Ontology (GO) analysis of target genes of the 12 most highly expressed miRNAs in PEMSC-derived EVs. Significantly enriched biological process terms include embryonic morphogenesis, regulation of cell population proliferation, and embryo development (p < 0.04). KEGG pathway analysis of target genes of the 12 most highly expressed miRNAs in PEMSC-derived EVs. The most significantly enriched pathways include the MAPK and PI3K-AKT signaling pathways (p < 0.03), which are involved in meiosis and cell cycle regulation. Experiment 3: Effects of selected miRNAs on embryo development Transfection efficiency was confirmed by RT-qPCR: miR-21-5p levels were significantly higher in transfected oocytes and cumulus cells compared to controls (Fig. 6, p < 0.05). miR-21-5p (50 nM) added during IVM (T2 group) produced a significantly higher blastocyst rate than other groups (18.91 ± 4.45%; p < 0.05; Table 5), thereby promoting the upregulation of Oct4 gene expression through CDK2AP1 suppression. miR-143-3p (50 nM) added during both IVM and IVC (T3) significantly increased the eight-cell cleavage rate (66.83 ± 2.48% vs. 47.07 ± 1.01%, p < 0.05; Table 6). No significant differences in blastocyst rate were observed. miR-381-3p added during both IVM and IVC (T3) produced a significantly lower blastocyst rate compared to IVM-only (T1) or IVC-only (T2) groups (4.56 ± 2.10% vs. 22.06 ± 6.65% and 19.86 ± 6.28%; p < 0.05; Table 7) ().Fig. 6RT-qPCR confirmation of miR-21-5p transfection in porcine oocytes and cumulus cells. Transfected cells showed significantly higher miR-21-5p levels than controls, confirming the feasibility of HiPerFect®-mediated miRNA delivery (RQ ± SD; *p < 0.05).Fig 6 dummy alt textTable 5Effects of IVM/IVC medium supplemented with miR-21-5p on the development of parthenogenetic activated porcine embryos.Table 5 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2-cells(%)4-cells(%)8-cells(%)Morula(%)Blastocysts (%)Control133181(68.39±1.91)79(94.22±1.77)76(90.67±2.95)58(69.56±4.09)41(49.11±3.82)6(7.33±2.32)b31.25±7.03T113384(88.11±3.01)71(73.93±3.54)54(55.79±5.20)40(41.42±7.53)1(0.8±0.80)b15.00±2.52T2135158(60.77±6.93)71(89.91±5.44)62(78.64±4.52)44(58.43±3.94)31(38.54±5.95)12(18.91±4.45)a29.5±5.15T313571(91.22±4.73)63(81.16±4.74)51(66.63±6.89)38(49.61±8.89)7(9.33±3.85)b28.71±4.85Control: TCM-199 medium for IVM/PZM medium for IVC.T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/ PZM medium for IVC.T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated five times.Table 6Effects of IVM/IVC medium supplemented with miR-143-3p on the development of parthenogenetic activated porcine embryos.Table 6 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2-cells(%)4-cells(%)8-cells(%)Morula(%)Blastocysts (%)Control147113(76.63±4.83)50(91.26±3.51)ab39(71.26±4.48)26(47.07±1.01)b18(32.93±1.27)6(10.65±1.35)23.5±6.70T148(95.53±2.72)a42(82.82±6.12)27(52.69±7.97)ab16(31.45±5.20)5(9.36±3.73)36.80±2.85T2144108(75.23±4.81)57(94.67±1.92)ab46(77.4±8.71)35(58.22±5.66)ab24(39.11±7.93)11(18.21±9.44)27.70±2.43T345(85.92±2.76)ab43(82.33±2.33)35(66.83±2.48)a25(47.63±2.94)9(17.56±3.55)31.22±4.25Control: TCM-199 medium for IVM/PZM medium for IVC.T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/PZM medium for IVC.T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated four times.Table 7Effects of IVM/IVC medium supplemented with miR-381-3p on the development of parthenogenetic activated porcine embryos.Table 7 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2 cells(%)4 cells(%)8 cells(%)Morula(%)Blastocysts (%)Control173121(69.08±4.41)53(91.45±3.50)44(79.32±7.60)33(60.91±8.96)18(32.92±4.76)7(12.34±1.35)ab22.8±2.62T161(96.15±3.85)56(88.12±5.53)43(69.50±9.73)32(50.82±6.05)14(22.06±6.65)a33.78±4.74T2169120(70.60±4.11)45(85.55±5.40)33(68.15±11.51)25(51.48±8.56)16(32.96±7.05)9(19.86±6.28)a29.17±4.04T353(94.25±2.66)46(83.16±4.18)33(60.56±6.17)23(41.59±4.15)3(4.56±2.10)b38.33±4.81Control: TCM-199 medium for IVM/PZM medium for IVC.T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/PZM medium for IVC.T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated six times. RT-qPCR confirmation of miR-21-5p transfection in porcine oocytes and cumulus cells. Transfected cells showed significantly higher miR-21-5p levels than controls, confirming the feasibility of HiPerFect®-mediated miRNA delivery (RQ ± SD; *p < 0.05). Table 5Effects of IVM/IVC medium supplemented with miR-21-5p on the development of parthenogenetic activated porcine embryos.Table 5 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2-cells(%)4-cells(%)8-cells(%)Morula(%)Blastocysts (%)Control133181(68.39±1.91)79(94.22±1.77)76(90.67±2.95)58(69.56±4.09)41(49.11±3.82)6(7.33±2.32)b31.25±7.03T113384(88.11±3.01)71(73.93±3.54)54(55.79±5.20)40(41.42±7.53)1(0.8±0.80)b15.00±2.52T2135158(60.77±6.93)71(89.91±5.44)62(78.64±4.52)44(58.43±3.94)31(38.54±5.95)12(18.91±4.45)a29.5±5.15T313571(91.22±4.73)63(81.16±4.74)51(66.63±6.89)38(49.61±8.89)7(9.33±3.85)b28.71±4.85Control: TCM-199 medium for IVM/PZM medium for IVC.T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/ PZM medium for IVC.T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated five times. Effects of IVM/IVC medium supplemented with miR-21-5p on the development of parthenogenetic activated porcine embryos. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/ PZM medium for IVC. T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC. represents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated five times. Table 6Effects of IVM/IVC medium supplemented with miR-143-3p on the development of parthenogenetic activated porcine embryos.Table 6 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2-cells(%)4-cells(%)8-cells(%)Morula(%)Blastocysts (%)Control147113(76.63±4.83)50(91.26±3.51)ab39(71.26±4.48)26(47.07±1.01)b18(32.93±1.27)6(10.65±1.35)23.5±6.70T148(95.53±2.72)a42(82.82±6.12)27(52.69±7.97)ab16(31.45±5.20)5(9.36±3.73)36.80±2.85T2144108(75.23±4.81)57(94.67±1.92)ab46(77.4±8.71)35(58.22±5.66)ab24(39.11±7.93)11(18.21±9.44)27.70±2.43T345(85.92±2.76)ab43(82.33±2.33)35(66.83±2.48)a25(47.63±2.94)9(17.56±3.55)31.22±4.25Control: TCM-199 medium for IVM/PZM medium for IVC.T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/PZM medium for IVC.T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated four times. Effects of IVM/IVC medium supplemented with miR-143-3p on the development of parthenogenetic activated porcine embryos. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/PZM medium for IVC. T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC. represents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated four times. Table 7Effects of IVM/IVC medium supplemented with miR-381-3p on the development of parthenogenetic activated porcine embryos.Table 7 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2 cells(%)4 cells(%)8 cells(%)Morula(%)Blastocysts (%)Control173121(69.08±4.41)53(91.45±3.50)44(79.32±7.60)33(60.91±8.96)18(32.92±4.76)7(12.34±1.35)ab22.8±2.62T161(96.15±3.85)56(88.12±5.53)43(69.50±9.73)32(50.82±6.05)14(22.06±6.65)a33.78±4.74T2169120(70.60±4.11)45(85.55±5.40)33(68.15±11.51)25(51.48±8.56)16(32.96±7.05)9(19.86±6.28)a29.17±4.04T353(94.25±2.66)46(83.16±4.18)33(60.56±6.17)23(41.59±4.15)3(4.56±2.10)b38.33±4.81Control: TCM-199 medium for IVM/PZM medium for IVC.T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/PZM medium for IVC.T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated six times. Effects of IVM/IVC medium supplemented with miR-381-3p on the development of parthenogenetic activated porcine embryos. Control: TCM-199 medium for IVM/PZM medium for IVC. T1: TCM-199 medium for IVM/ PZM medium with miRNA for IVC. T2: TCM-199 medium with miRNA for IVM/PZM medium for IVC. T3: TCM-199 medium with miRNA for IVM/PZM medium with miRNA for IVC. represents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated six times. Experiment 4: miR-21-5p regulates CDK2AP1 and Oct4 in porcine blastocysts The miR-21-5p overexpression group (21+) showed a significantly higher blastocyst rate than the control and inhibitor (21−) groups (22.48 ± 2.69% vs. 12.42 ± 1.23% and 3.95 ± 1.66%, p < 0.05; Table 8). Total cell counts were also significantly higher in 21+ versus 21− (47.25 ± 3.70 vs. 26.33 ± 1.76, p < 0.05).Table 8Effects of IVM /IVC medium supplemented with miR-21-3p or its inhibitor on the development of parthenogenetic activated porcine embryos.Table 8 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2-cells(%)4-cells(%)8-cells(%)Morula(%)Blastocysts (%)Control10370(69.9±6.06)61(90.08±5.30)54(80.64±7.16)43(65.08±9.73)24(36.03±5.20)8(12.42±1.23)b38.63±3.61ab21+8759(68.84±5.26)55(94.42±2.44)49(83.27±7.32)38(65.10±7.25)28(47.24±7.96)13(22.48±2.69)a47.25±3.70a21-10565(65.53±4.79)59(93.57±2.77)51(82.00±5.25)38(64.08±10.67)26(41.95±5.87)3(3.98±1.66)c26.33±1.76bControl: TCM-199 medium for IVM/PZM medium for IVC. 21+: TCM-199 medium with miR-21-5p for IVM.21-: TCM-199 medium with miRNA21-5p-inhibitor for IVM.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated five times.Corresponding author: Steven W. Shaw 2024/10/16 Table 8Effects of IVM /IVC medium supplemented with miR-21-3p or its inhibitor on the development of parthenogenetic activated porcine embryos.Table 8 dummy alt textTreatment groupTotal no. of oocytesMaturation rate (%)Embryo stage of IVCCell no. of Blastocysts2-cells(%)4-cells(%)8-cells(%)Morula(%)Blastocysts (%)Control10370(69.9±6.06)61(90.08±5.30)54(80.64±7.16)43(65.08±9.73)24(36.03±5.20)8(12.42±1.23)b38.63±3.61ab21+8759(68.84±5.26)55(94.42±2.44)49(83.27±7.32)38(65.10±7.25)28(47.24±7.96)13(22.48±2.69)a47.25±3.70a21-10565(65.53±4.79)59(93.57±2.77)51(82.00±5.25)38(64.08±10.67)26(41.95±5.87)3(3.98±1.66)c26.33±1.76bControl: TCM-199 medium for IVM/PZM medium for IVC. 21+: TCM-199 medium with miR-21-5p for IVM.21-: TCM-199 medium with miRNA21-5p-inhibitor for IVM.a,brepresents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated five times.Corresponding author: Steven W. Shaw 2024/10/16 Effects of IVM /IVC medium supplemented with miR-21-3p or its inhibitor on the development of parthenogenetic activated porcine embryos. Control: TCM-199 medium for IVM/PZM medium for IVC. 21+: TCM-199 medium with miR-21-5p for IVM. 21-: TCM-199 medium with miRNA21-5p-inhibitor for IVM. represents the significant difference (p < 0.05), value was presented as Mean ± SEM. This experiment was repeated five times. Corresponding author: Steven W. Shaw 2024/10/16 RT-qPCR showed that miR-21-5p significantly downregulated CDK2AP1 (Control: 1.05 ± 0.03; 21+: 0.75 ± 0.10; 21−: 0.41 ± 0.06; p < 0.05) and significantly upregulated Oct4/POU5F1 (Control: 0.84 ± 0.07; 21+: 1.29 ± 0.25; 21−: 0.39 ± 0.03; p < 0.05) (Fig. 7).Fig. 7Expression of POU5F1 (Oct4) and CDK2AP1 in porcine blastocysts following miR-21-5p overexpression (miR-21-5p) or inhibition (inhibitor) compared to control. miR-21-5p significantly upregulated Oct4 and downregulated CDK2AP1. N = 15 per group; experiment repeated three times. (RQ ± SEM; *p < 0.05, **p < 0.01).Fig 7 dummy alt text Expression of POU5F1 (Oct4) and CDK2AP1 in porcine blastocysts following miR-21-5p overexpression (miR-21-5p) or inhibition (inhibitor) compared to control. miR-21-5p significantly upregulated Oct4 and downregulated CDK2AP1. N = 15 per group; experiment repeated three times. (RQ ± SEM; *p < 0.05, **p < 0.01). Discussion In Experiment 1, PEMSC-conditioned medium enhanced oocyte maturation (polar body extrusion) but did not improve blastocyst rates. The observed variability in oocyte cytoplasmic quality may be attributed to differences in pig breed, age, rearing environment, and feed composition, as ovaries were obtained from a commercial abattoir. Commercial pigs are slaughtered at approximately six months of age, when uterine and ovarian development may still be incomplete, potentially limiting the impact of endometrial secretions on embryo development. Regarding the physiological route by which stromal-derived EVs might access the uterine lumen in vivo: stromal-epithelial EV exchange is documented in the endometrium, and mesenchymal-derived EVs may act indirectly by modulating luminal or glandular epithelial cells, which in turn secrete EVs into the uterine lumen. In our experimental design, PEMSCs serve as an accessible and well-characterized in vitro source of MSC-derived EVs for supplementation, not as a simulation of the in vivo physiological route. Future work should evaluate EVs derived from luminal and glandular epithelial cells as more physiologically direct candidates for uterine-embryo communication. Studies on polycystic ovary syndrome (PCOS) have shown that high levels of miR-143-3p in follicular fluid lead to abnormal glycolysis in granulosa cells (Cao et al., 2022). Despite this negative follicular effect, upregulation of miR-143-3p promotes proliferation and migration of porcine trophoblast cells (Ding et al., 2022). The significant increase in eight-cell cleavage rate with miR-143-3p addition in our study warrants further investigation into its stage-specific regulatory role in early porcine embryogenesis. The role of miR-381-3p in embryo development remains unexplored in pigs. In human IVC media associated with successful implantation, miR-381-3p has been linked to cell adhesion and stem cell pluripotency pathways (Timofeeva et al., 2021). The negative effect observed in T3 (IVM+IVC) suggests that dual-stage supplementation may disrupt developmental signaling, but further investigation is required. In Experiment 4, the CDK2AP1–miR-21-5p–Oct4 regulatory axis was confirmed in porcine blastocysts. These findings are consistent with reports in mouse embryonic stem cells where CDK2AP1 silences Oct4 and miR-21 relieves this suppression (Alsayegh et al., 2018; Mihalič et al., 2023). Species-specific differences in this regulatory axis — particularly between mouse, human, and pig — should be considered when interpreting these results and designing future translational studies. A key limitation of this study is the use of slaughterhouse-derived tissues from animals at unknown stages of the estrous cycle. Endometrial cell composition and secretory activity are known to vary with cycle stage, and future studies should use tissues collected at defined cycle stages to better characterize PEMSC-derived EVs. Additionally, the presence of endogenous EVs in PFF used in IVM medium represents a confounding factor that should be controlled for in future work, for instance by using EV-depleted PFF. Conclusion The conditioned medium of porcine endometrial mesenchymal stem cells (PEMSCs) promotes porcine oocyte maturation in vitro. Specifically, miR-21-5p effectively enhances Oct4 expression, thereby improving the blastocyst formation rate, through suppression of CDK2AP1. miR-143-3p supplementation increases the eight-cell cleavage rate, suggesting a regulatory role in early embryonic cell division. The miRNA cargo of PEMSC-derived EVs holds promise for improving in vitro production of porcine embryos, with future translational applications in human infertility treatment, livestock production, and conservation of endangered species. Ethical statement •This work described has not been published previously except in the form of a preprint, an abstract, a published lecture, academic thesis or registered report.•This article is not under consideration for publication elsewhere.•This article's publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out.•if accepted, the article will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright-holder. •This work described has not been published previously except in the form of a preprint, an abstract, a published lecture, academic thesis or registered report. This work described has not been published previously except in the form of a preprint, an abstract, a published lecture, academic thesis or registered report. •This article is not under consideration for publication elsewhere. This article is not under consideration for publication elsewhere. •This article's publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out. This article's publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out. •if accepted, the article will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright-holder. if accepted, the article will not be published elsewhere in the same form, in English or in any other language, including electronically, without the written consent of the copyright-holder. CRediT authorship contribution statement Shao-Yu Peng: Formal analysis. Yen Feng: Funding acquisition. Min-Jung Lin: Investigation. Shen-Chang Chang: Methodology. Jung-Wen Huang: Project administration. Perng-Chih Shen: Writing – original draft. Kuo-Tai Yang: Writing – review & editing. Chao-Wei Huang: Validation. Chih-Jen Chou: Supervision. Steven W. Shaw: Conceptualization. Declaration of competing interest The authors declared no conflict of interest regarding this study.